| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.048 | 0.9 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.9 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |